Aktie 565171 SAPPORO CLINICAL LABORATORY INC.
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren

Andere Sprachen Sapporo Clinical Laboratory Inc.

Aktien

565171

JP3321100004

9776

Verzögert Japan Exchange
Andere Börsenplätze
 02:30:28 18.07.2024 		% 5 Tage % 1. Jan.
1 007 JPY -0,10 % Intraday Chart für Sapporo Clinical Laboratory Inc. -0,20 % +0,60 %
26.02. Sapporo Clinical Laboratory Inc. (TSE:9776) kündigt einen Aktienrückkauf für 232.100 Aktien an, was 6,97% für ¥209,12 Millionen entspricht. CI
26.02. Sapporo Clinical Laboratory Inc. autorisiert einen Rückkaufplan. CI

Andere Sprachen

Suchen
Ergebnisse ansehen
Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!
100% kostenlose Registrierung
Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on February 26, 2024.
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on March 26, 2024, has closed with 210,800 shares, representing 6.33% for ¥189.93 million.
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 232,100 shares, representing 6.97% for ¥209.12 million.
Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.
Sapporo Clinical Laboratory Inc. Reports Earnings Results for the Full Year Ended March 31, 2023
Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on May 30, 2022.
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on May 30, 2022 has closed with 22,700 shares, representing 0.67% for ¥29.21 million.
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 22,700 shares, representing 0.68% for ¥29.21 million.
Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.
Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on February 28, 2022.
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on February 28, 2022, has closed with 53,700 shares, representing 1.58% for ¥69.11 million.
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 53,700 shares, representing 1.58% for ¥69.11 million.
Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.
Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on June 21, 2021.
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on June 21, 2021, has closed with 16,300 shares, representing 0.48% for ¥25.92 million.
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 16,300 shares, representing 0.48% for ¥25.92 million.
Sapporo Clinical Laboratory Inc. authorizes a Buyback Plan.
Tranche Update on Sapporo Clinical Laboratory Inc.'s Equity Buyback Plan announced on June 26, 2018.
Sapporo Clinical Laboratory Inc.'s Equity Buyback announced on June 26, 2018 has expired with 39,200 shares, representing 1.13% for ¥96 million.
Sapporo Clinical Laboratory Inc. announces an Equity Buyback for 45,000 shares, representing 1.3% for ¥110.21 million.
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. 565171 Aktie
  4. Nachrichten Sapporo Clinical Laboratory Inc.
  5. Andere Sprachen